Abdominal Electrical Stimulation for Balance and Muscle Thickness in Stroke Patients
Condition(s) studied
Investigational drug(s) / intervention(s)
Neuromuscular Electrical Stimulation: NMES will be applied to the abdominal muscles using a multichannel stimulator. Each session will last approximately 20 minutes, administered 5 times per week for a total of 15 sessions, in addition to core stabilization exercise program performed with the same frequency.
Core Stabilization Exercises: Participants will perform a structured core stabilization exercise program. The program will be administered 5 times per week for a total of 15 sessions.
Study summary
Stroke is a leading cause of balance impairment and trunk muscle weakness, which restricts independence in daily activities. Neuromuscular electrical stimulation (NMES) is a safe rehabilitation method to activate muscles. This study will evaluate the effects of NMES applied to the abdominal muscles on balance and ultrasound-measured muscle thickness in stroke patients. The findings may provide evidence for new treatment strategies to enhance trunk function and improve quality of life after stroke.
Eligibility
Primary outcome measure(s)
- Change in Balance Performance (Berg Balance Scale) — Baseline and after 15 sessions (≈3 weeks)
Balance will be assessed using the Berg Balance Scale (BBS; maximum score: 56, minimum score: 0). Higher scores indicate better balance, lower scores indicate worse balance. - Abdominal Muscle Thickness (Ultrasound) — Baseline and after 15 sessions (≈3 weeks)]
Abdominal muscle thickness will be measured in millimeters by ultrasound at rest. Higher values indicate greater muscle thickness.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Başakşehir Çam and Sakura City Hospital | Istanbul | Turkey (Türkiye) |
More Başakşehir Çam & Sakura City Hospital trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07143630 on ClinicalTrials.gov ↗ ← All trials in Turkey